Liver disease: Conscious uncoupling in NASH

Nature Reviews Drug Discovery 16, 238 (2017). doi:10.1038/nrd.2017.60 Author: M. Teresa Villanueva Non-alcoholic steatohepatitis (NASH) — an inflammatory disease that can progress to cirrhosis and end-stage liver disease — is becoming increasingly common, and there are no approved pharmacological therapies. Wang et al. have now identified that CASP8 and FADD-like apoptosis regulator (CFLAR) can suppress steatohepatitis
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research